Cross-bridged cyclen or cyclam Co(III) complexes containing cytotoxic ligands as hypoxia-activated prodrugs

Inorganic Chemistry

Volumn 52, Issue 13, 2013, Pages 7688-7698

  Chang, John Yu Chih ^a   Lu, Guo Liang ^b   Stevenson, Ralph J ^b   Brothers, Penelope J ^a   Clark, George R ^a   Botting, K Jane ^b   Ferry, Dianne M ^b   Tercel, Moana ^b   Wilson, William R ^b   Denny, William A ^b   Ware, David C ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE; ANTINEOPLASTIC AGENT; COBALT; COORDINATION COMPOUND; CYCLAM; HETEROCYCLIC COMPOUND; LIGAND; PRODRUG;

ANIMAL; ARTICLE; CELL HYPOXIA; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; MOUSE; NEOPLASM; TUMOR CELL LINE; X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL HYPOXIA; CELL LINE, TUMOR; COBALT; COORDINATION COMPLEXES; CRYSTALLOGRAPHY, X-RAY; HETEROCYCLIC COMPOUNDS; HUMANS; LIGANDS; MICE; MODELS, MOLECULAR; NEOPLASMS; PRODRUGS;

EID: 84879774309     PISSN: 00201669     EISSN: 1520510X     Source Type: Journal    
DOI: 10.1021/ic4006967     Document Type: Article

References (34)

1. Hall, M. D.; Failes, T. W; Natsuho Yamamotoa, N.; Hambley, T. W. Bioreductive activation and drug chaperoning in cobalt pharmaceuticals Dalton Trans. 2007, 3983-3990
2. Ware, D. C.; Palmer, B. D.; Wilson, W. R.; Denny, W. A. Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards are a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards J. Med. Chem. 1993, 36, 1839-1846
3. Failes, T. W.; Cullinane, C.; Diakos, C. I.; Yamamoto, N.; Lyons, J. G.; Hambley, T. W. Studies of a cobalt (III) complex of the MMP inhibitor marimastat: a potential hypoxia-activated prodrug Chem.-Eur. J. 2007, 13, 2974-2982
4. Ahn, G.-O.; Botting, K. J.; Patterson, A. V.; Ware, D. C.; Tercel, M.; Wilson, W. R. Radiolytic and cellular reduction of a novel hypoxia-activated cobalt (III) prodrug of a chloromethylbenzindoline DNA minor groove alkylator Biochem. Pharmacol. 2006, 71, 1683-1694
5. Anderson, R. F.; Denny, W. A.; Ware, D. C.; Wilson, W. R. Pulse radiolysis studies on the mechanism of hypoxia-selective cytotoxicity of the cobalt(III)-nitrogen mustard complex SN 24771 Br. J. Cancer 1996, 74 (Suppl. 27) S48-S51
6. Ware, D. C.; Palmer, H. R.; Pruijn, F. B.; Anderson, R. F.; Brothers, P. J.; Denny, W. A.; Wilson, W. R. Bis(dialkyl)dithiocarbamato cobalt(III) complexes of bidentate nitrogen mustards: synthesis, reduction chemistry and biological evaluation as hypoxia-selective cytotoxins Anti-Cancer Drug Des. 1998, 13, 81-103
7. Ahn, G.-O.; Ware, D. C.; Denny, W. A.; Wilson, W. R. Optimization of the auxiliary ligand shell of cobalt(III)(8-hydroxyquinoline) complexes as model hypoxia-selective radiation-activated prodrugs Radiat. Res. 2004, 162, 315-325
8. Milbank, J. B. J.; Stevenson, R. J.; Ware, D. C.; Chang, J. Y.-C.; Tercel, M.; Ahn, G.-O.; Wilson, W. R.; Denny, W. A. Synthesis and evaluation of stable bidentate transition metal complexes of 1-(chloromethyl)-5-hydroxy-3-(5, 6,7-trimethoxyindol-2-ylcarbonyl)-2,3-dihydro-1H-pyrrolo[3,2-f]quinoline (seco-6-azaCBI-TMI) as hypoxia selective cytotoxins J. Med. Chem. 2009, 52, 6822-6834
9. Lu, G.-L.; Stevenson, R. J.; Chang, J. Y.-C.; Brothers, P. J.; Ware, D. C.; Wilson, W. R.; Denny, W. A.; Tercel, M. N-Alkylated cyclen cobalt(III) complexes of 1-(chloromethyl)-3-(5,6,7-trimethoxyindol-2-ylcarbonyl)-2,3- dihydro-1H-pyrrolo[3,2-f]quinolin-5-ol DNA alkylating agent as hypoxia-activated prodrugs Bioorg. Med. Chem. 2011, 19, 4861-4867
10. Chang, J. Y.-C.; Stevenson, R. J.; Lu, G.-L.; Brothers, P. J.; Clark, G. R.; Denny, W. A.; Ware, D. C. Syntheses of 8-quinolinolatocobalt(III) complexes containing cyclen based auxiliary ligands as models for hypoxia-activated prodrugs Dalton Trans. 2010, 39, 11535-11550
11. Boger, D. L.; Yun, W. CBI-TMI: Synthesis and evaluation of a key analog of the duocarmycins. validation of a direct relationship between chemical solvolytic stability and cytotoxic potency and confirmation of the structural features responsible for the distinguishing behavior of enantiomeric pairs of agents J. Am. Chem. Soc. 1994, 116, 7996-8006
12. Boger, D. L.; Boyce, C. W. Selective metal cation activation of a DNA alkylating agent; synthesis and evaluation of methyl 1,2,9,9a- tetrahydrocycloprop[c]pyrido[3,2-e]indol-4-7-carboxylate (CPyI) J. Org. Chem. 2000, 65, 4088-4100
13. Boger, D. L.; Wolkenberg, S. E.; Boyce, C. W. A new method of in situ activation for a novel class of DNA alkylating agents: tunable metal cation complexation and activation J. Am. Chem. Soc. 2000, 122, 6325-632613
14. Busch, D. H. The complete coordination chemistry-one practitioner's perspective Chem. Rev. 1993, 93, 847-860
15. Bencini, A.; Bianchi, A.; Bazzicalupi, C.; Ciampolini, M.; Fusi, V.; Micheloni, M.; Nardi, N.; Paoli, P.; Valtancoli, B. Proton inclusion properties of a new azamacrocycle. Synthesis, characterization and crystal structure of [H3L][Cl]3·2H2O (L = 4,10-dimethyl-1,4,7,10-tetraazabicyclo[5.5.2] tetradecane) Supramol. Chem. 1994, 3, 141-146
16. Springborg, J.; Olsen, C. E.; Søtofte, I. An inert proton coordinated inside a nearly tetrahedral tetraamine cavity. Synthesis and X-ray crystal structure of the aquatrichlorozincate(II) salt of the inside monoprotonated amine 1,4,8,11-tetraazatricyclo[6.6.2.2(4,1)]octadecane Acta Chem. Scand. 1995, 49, 555-563
17. +) complexation in a diamond-lattice cleft J. Am. Chem. Soc. 1990, 112, 8604-8605
18. Weisman, G. R.; Wong, E. H.; Hill, D. C.; Rogers, M. E.; Reed, D. P.; Calabrese, J. C. Synthesis and transition-metal complexes of new cross-bridged tetraamine ligands Chem. Commun. 1996, 947-948
19. Wong, E. H.; Weisman, G. R.; Hill, D. C.; Reed, D. P.; Rogers, M. E.; Condon, J. S.; Fagan, M. A.; Calabrese, J. C.; Lam, K.-C.; Guzei, I. A.; Rheingold, A. L. Synthesis and characterization of cross-bridged cyclams and pendant-armed derivatives and structural studies of their copper(II) complexes J. Am. Chem. Soc. 2000, 122, 10561-10572
20. Niu, W.; Wong, E. H.; Weisman, G. R.; Hill, D. C.; Tranchemontagne, D. J.; Lam, K.-C.; Sommer, R. D.; Zakharov, L. N.; Rheingold, A. L. Inside or outside a ligand cleft? Synthetic, structural, and kinetic inertness studies of zinc, cadmium, and mercury complexes of cross-bridged cyclam and cyclen Dalton Trans. 2004, 3536-3547
21. Hubin, T. J.; McCormick, J. M.; Collinson, S. R.; Buchalova, M.; Perkins, C. M.; Alcock, N. W.; Kahol, P. K.; Raghunathan, A.; Busch, D. H. New iron(II) and manganese(II) complexes of two ultra-rigid, cross-bridged tetraazamacrocycles for catalysis and biomimicry J. Am. Chem. Soc. 2000, 122, 2512-2522
22. Hubin, T. J.; Alcock, N. W.; Clase, H. J.; Seib, L. L.; Busch, D. H. Synthesis, characterization, and X-ray crystal structures of cobalt(II) and cobalt(III) complexes of four topologically constrained tetraazamacrocycles Inorg. Chim. Acta 2002, 337, 91-102
23. Hubin, T. J.; McCormick, J. M.; Collinson, S. R.; Alcock, N. W.; Clase, H. J.; Busch, D. H. Synthesis and X-ray crystal structures of iron(II) and manganese(II) complexes of unsubstituted and benzyl substituted cross-bridged tetraazamacrocycles Inorg. Chim. Acta 2003, 346, 76-86
24. Purcell, W. L. Dichlorotetrakis(pyridine)cobalt(III): a versatile and facile synthetic precursor Inorg. Chem. 1986, 25, 4068-4069
25. Bauer, F.; Drinkard, W. C. Sodium tricarbonatocobaltate(III) trihydrate Inorg. Synth. 1966, 8, 202-204
26. Springborg, J. Adamanzanes-bi- and tricyclic tetraamines and their coordination Dalton Trans. 2003, 1653-1665
27. Meyerstein, D. Are M-N bonds indeed inherently weaker when N is a tertiary rather than a primary or secondary nitrogen atom? Coord. Chem. Rev. 1999, 185-186, 141-147
28. Buxton, G. V. Radiation chemistry of the liquid state: (1) Water and homogeneous aaqueous solution. In Radiation Chemistry: Principles and Applications; Farhat-aziz; Rogers, M. A. J., Eds.; VCH: New York, 1987; pp 321-349.
29. Wilson, W. R.; Hicks, K. O.; Pullen, S. M.; Ferry, D. M.; Helsby, N. A.; Patterson, A. V. Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustards Radiat. Res. 2007, 167, 625-636
30. Wilson, W. R.; Hay, M. P. Targeting hypoxia in cancer therapy Nat. Rev. Cancer 2011, 11, 393-410
31. Elgy, C. N.; Wells, C. F. Kinetics of solvolysis of the trans-dichlorotetrapyridinecobalt(III) ion in water and in water + methanol J. Chem. Soc., Dalton Trans. 1980, 2405-2409
32. Miyahara, Y.; Tanaka, Y.; Amimoto, K.; Akazawa, T.; Sakuragi, T.; Kobayashi, H.; Kubota, K.; Suenaga, M.; Koyama, H.; Inazu, T. The proton cryptate of hexaethylenetetramine Angew. Chem., Int. Ed. 1999, 38, 956-959
33. Guise, C. P.; Abbattista, M. R.; Singleton, R. S.; Holford, S. D.; Connolly, J.; Dachs, G. U.; Fox, S. B.; Pollock, R.; Harvey, J.; Guilford, P.; Doñate, F.; Wilson, W. R.; Patterson, A. V. The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3 Cancer Res. 2010, 70, 1573-1584
34. Hicks, K. O.; Siim, B. G.; Jaiswal, J. K.; Pruijn, F. B.; Fraser, A. M.; Patel, R.; Hogg, A.; Liyanage, H. D. S.; Dorie, M. J.; Brown, J. M.; Denny, W. A.; Hay, M. P.; Wilson, W. R. Pharmacokinetic/ pharmacodynamic modeling identifies SN30000 and SN29751 as tirapazamine analogues with improved tissue penetration and hypoxic cell killing in tumors Clin. Cancer Res. 2010, 16, 4946-4957